TreeFrog Therapeutics and Invetech expand partnership to transition high-throughput stem cell encapsulation technology to GMP system for commercial-scale cell therapy manufacturing
https://youtu.be/SW25zIr_QR8The two companies started their collaboration in 2019 to industrialize TreeFrog’s stem cell encapsulation technology, to enable the mass production of hPSC-derived cell therapies in industrial bioreactors, with best-in-class cell quality and low production costs. Invetech delivered a beta encapsulation system with a throughput of 1,000...
07 October, 2020